Announced Tue, 21 Jul · 17:33 IST
Viyash Scientific signs SPA to acquire BioForLife Italia for about EUR 17 million
VIYASH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-4.7%1-day move
₹265.35
prior close
₹266.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-1.1-2.3-3.0-3.4-4.7-5.4-1.9———————
Up moveDown movePending
AI summary
Viyash Scientific's step-down wholly owned subsidiary Alivira Animal Health has signed a Sale and Purchase Agreement to acquire 100% of Italy-based BioForLife Italia S.r.l. Base consideration is about EUR 16.976 million, with EUR 15 million payable at closing and about EUR 1.976 million as retained or deferred payment linked to contractual-continuation conditions. Closing is subject to Italian FDI or Golden Power clearance. Other terms remain unchanged from the June 8, 2026 disclosure.
Likely market impact
European expansion via acquisition; EUR 17 million deal pending Italian regulatory clearance.